Disc Medicine, Inc.

IRON Healthcare Biotechnology

In the quarter to June 2026, EPS grew 2.53%, free cash flow grew 7.83% and total debt rose 106.5%, each against the same quarter a year earlier.

56.80 0.15 +0.26%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Current Ratio
24.14 24.00 21.94 23.45

+8 more quarters

Net Debt/EBITDA
10.06 9.94 11.12 8.46
Debt/Equity
0.09 0.04 0.04 0.05
Free Cash Flow per Share
(1.14) (1.62) (1.23) (1.36)
Book value per Share
16.65 17.89 20.96 16.30
Free Cash Flow
(44.20) (62.24) (43.32) (47.82)
Other line items

Show all line items

Columns are period end dates